Tezepelumab Home Use Study
Public ClinicalTrials.gov record NCT03968978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Open-label, Parallel Group, Functionality, and Performance Study of an Accessorized Pre-filled Syringe and Autoinjector With Home-administered Subcutaneous Tezepelumab in Adolescent and Adult Subjects With Severe Asthma (PATH-HOME)
Study identification
- NCT ID
- NCT03968978
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 216 participants
Conditions and interventions
Conditions
Interventions
- Tezepelumab (APFS) Biological
- Tezepelumab (AI) Biological
Biological
Eligibility (public fields only)
- Age range
- 12 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 20, 2019
- Primary completion
- Jun 4, 2020
- Completion
- Jun 4, 2020
- Last update posted
- Jul 28, 2021
2019 – 2020
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Hoover | Alabama | 35244 | — |
| Research Site | Gilbert | Arizona | 85234 | — |
| Research Site | Northridge | California | 91324 | — |
| Research Site | Palm Desert | California | 92260 | — |
| Research Site | Westminster | California | 92683 | — |
| Research Site | Tampa | Florida | 33607 | — |
| Research Site | Savannah | Georgia | 31406 | — |
| Research Site | Omaha | Nebraska | 68114 | — |
| Research Site | Northfield | New Jersey | 08225 | — |
| Research Site | Cincinnati | Ohio | 45231 | — |
| Research Site | Edmond | Oklahoma | 73034 | — |
| Research Site | Medford | Oregon | 97504 | — |
| Research Site | Dallas | Texas | 75235 | — |
| Research Site | McKinney | Texas | 75069 | — |
| Research Site | San Antonio | Texas | 78221 | — |
| Research Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03968978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 28, 2021 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03968978 live on ClinicalTrials.gov.